Boehringer Ingelheim India and PPAM begin rabies awareness drive in Mumbai schools

MUMBAI, India, Oct. 19, 2023 /PRNewswire/ -- Boehringer Ingelheim India, in partnership with the Pet Practitioners Association of Mumbai (PPAM), recently held an educational session at Mumbai Public School, Colaba. This session is a part of the month-long 'Stop Rabies' initiative in Mumbai. The initiative's primary goal is to drive anti-rabies vaccinations rates among uncared animals, educate children about rabies and underscore the importance of the relationship between humans and animals and its impact on overall public health. 

Over 100 students participated in the educational session. As part of the sessions, students were also provided with an educational kit comprising puzzles, stationery, and a booklet with information on rabies. 

The attendees from Boehringer Ingelheim included members from the organisation's regional executive committee: Tawil Mohammed, Regional Managing Director & Head of Human Pharma, Middle East Turkey and Africa (IMETA), Christoph Raab, Head of Finance and Administration, IMETA, Arif Haq, Head of Legal & Compliance, IMETA. The India leadership team was represented by Gagandeep Singh Bedi, Managing Director and Head of Human Pharma, Dr. Vinod Gopal, Director and Country Head of Animal Health and Priya Chandramohan, Director, Communication. Additionally, Dr. Makarand Chavan represented PPAM.

"The 'Stop Rabies' initiative, in collaboration with Boehringer Ingelheim India and PPAM, is a timely response to a pressing need in Mumbai. From the launch we've successfully vaccinated over 15000+ dogs. We are determined to continue this momentum and ensure that every uncared-for dog in our city is vaccinated under this initiative," said Dr. Kalimpasha A. Pathan, General Manager, Veterinary Health Department and Deonar Abattoir, Brihanmumbai Muncipal Corporation.

"The campaign showcases our unwavering commitment to sustainability within the 'More Health' pillar, an essential element of our 'Sustainable Development - For Generations' framework. At Boehringer Ingelheim, we believe in 'One Health' for the planet, animals, and humans, and this initiative is a step towards that vision," said Tawil Mohammed, Regional Managing Director & Head of Human Pharma, IMETA. "It was energizing to join the young minds and witness their eagerness to learn about the human animal bond", he added.

"Rabies awareness is not just a medical concern, but a societal one. Our collaboration with PPAM and BMC is a reflection of our dedication to creating a safer, more informed community. Awareness is the first step towards building a healthier society and it starts by educating the young minds who will play an important role in the years to come," said Gagandeep Singh Bedi, Managing Director and Head of Human Pharma at Boehringer Ingelheim India. 

About Boehringer Ingelheim 

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since Boehringer Ingelheim takes a long-term perspective. Around 53,000 employees serve more than 130 markets in three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. 

Learn more at www.boehringer-ingelheim.com 

Established in 2003, Boehringer Ingelheim India manages India and the neighboring markets' operations of the global enterprise. The Company enables access to innovative products as part of its Human Pharma and Animal Health businesses. The focus Human Pharma therapy areas include diabetes, cardiovascular, and respiratory conditions.  

Learn more at www.boehringer-ingelheim.in 

About 'Sustainable Development – For Generations' 

Boehringer Ingelheim operates to serve the needs of human and animal health. This makes the company's position unique in addressing intersecting sustainable development challenges. The 'Sustainable Development – For Generations' framework has three pillars: 'More Health', 'More Green' and 'More Potential'. Through these pillars, Boehringer Ingelheim implements 20 initiatives around the globe to drive the company's contributions and impact. These are in alignment with the United Nations Sustainable Development Goals. To succeed in reaching these goals, the company has renewed its committed approach to working in partnership, calling for the multi-stakeholder collaboration needed to tackle complex global challenges. 

About Pet Practitioners Association of Mumbai 

PPAM is a social professional and educational registered trust for welfare of the pet /vet fraternity, which is an organization working for pet medicine in India. The objectives of PPAM is to drive scientific education to enable members to better serve the pet population. Learn more at  http://www.ppam.co.in/ 

Photo: https://mma.prnewswire.com/media/2250962/Boehringer_Ingelheim_India_and_PPAM.jpg